73
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
297813
miRoncol Diagnostics offers affordable, accurate multi-cancer early detection blood tests using miRNA biomarkers.
- Victoria Xu: CEO and Co-FounderPast Role: CleanInnoGen, Co-Founder & CEO
About the Company
miRoncol Diagnostics focuses on democratizing access to cancer screening through accurate and affordable multi-cancer early detection blood tests. Utilizing miRNA as a biomarker, miRoncol has developed the first miRNA-based multi-cancer detection model. The company aims to make early cancer detection accessible to everyone by leveraging PCR
technology, which is both mature and cost-effective, allowing for rapid global expansion.
